1

MedPacto

MedPacto
Leadership team

Seong-Jin Kim (Founder)

Products/ Services
Biotechnology, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Seocho, Seoul-t'ukpyolsi, South Korea
Established
2013
Traded as
KRX:235980
Social Media
Overview
Location
Summary
MedPacto Inc. is a biopharmaceutical company focused on the discovery and development of innovative cancer therapies.
History

MedPacto was founded in 2012 by a range of scientists and clinical experts in cancer and translational medicine. Early discoveries have translated into preclinical and clinical programs targeting cancers with high unmet needs.

Mission
Our mission is to be the premier provider of targeted therapeutic products that provide safer and more effective treatment options for those affected by cancer.
Vision
Our vision is to be the leader in the development of innovative cancer therapies that improve lives, reduce suffering and expand patient's treatment options.
Key Team

Seong-Jin Kim (Founder)

Recognition and Awards
MedPacto has been recognized by a number of prestigious awards, including the Prix Galien Award, the GSK Award for Innovation in Translational Medicine, and the Sanofi Aid for Cancer Research Prize
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

MedPacto
Leadership team

Seong-Jin Kim (Founder)

Products/ Services
Biotechnology, Pharmaceutical
Number of Employees
50 - 100
Headquarters
Seocho, Seoul-t'ukpyolsi, South Korea
Established
2013
Traded as
KRX:235980
Social Media